Download the Schedule at a Glance
Please Note: All times are listed in Central Time
Thursday-Saturday, October 23-25, 2025
JW Marriott Austin
Wednesday October 22
4:00pm - 8:00pm | Exhibitor Move-In
4:00pm - 5:00pm | Pharma Commercial Meeting
5:00pm - 6:00pm | Pharma Science/Education Meeting
5:00pm - 8:00pm | Poster Board Set-up for Presenters
Thursday October 23
SYMPOSIUM DAY 1
6:00am - 8:00am | Exhibitor Final Move-In
6:00am - 7:00am | Final Poster Board Set-up for Presenters
7:00am - 8:00am | Poster Hall Breakfast
8:00am - 10:00am | Guidelines Working Meetings and Other Society Meetings (by appointment with NANETS Staff)
8:00am - 8:10am | Welcome and Announcements
8:15am - 9:15am | Rodger C. Haggitt Gastrointestinal Pathology Society (GIPS) Joint Session: Updates in Pathologic, Immunohistochemical, and Genetic Features of Gastrointestinal Tract Neuroendocrine Neoplasms
Moderator: Raul S. Gonzalez, MD, Professor, Director of Anatomic Pathology Research, Director of the Gastrointestinal Pathology Service, Emory University School of Medicine
Topic: Overview of IHC NEN Evaluation
Speaker: Andrew Bellizzi, MD, Clinical Professor of Pathology, The University of Iowa
Topic: Diagnosis, Genetics, and Progression of NENs - Pathologist Perspective
Speaker: Nancy Joseph, MD, PhD, Professor, Pathology, The University of California, San Francisco
Topic: Site-specific updates and best practices in Digestive Tract Neuroendocrine Neoplasms
Speaker: Deyali Chatterjee, MBBS, Associate Professor of Pathology, Microbiology and Immunology, Vanderbilt University
9:20am - 10:20am | Society of Nuclear Medicine and Molecular Imaging Joint Session: Advancing NET Theranostics: Evolving Insights in NET Theranostics and Patient Care
Moderator: Shana Elman, MD, Program Director and Associate Professor, The University of New Mexico
Topic: Early vs. Late introduction of PRRT
Speaker: Amir Iravani, MD, Associate Professor, University of Washington; Theranostics Clinical Director for Fred Hutchinson Cancer Center
Topic: Rationale of Instructions and Follow-Up for Patients in NM: Challenges and Evolving Perspectives
Speaker: Harshad Kulkarni, MD, Chief Medical Advisor, BAMF Health
Topic: NET Theranostics: Clinical Considerations of Patient Care Management
Speaker: Megan Hungerford, CNMT, Manager Nuclear Medicine & PET/CT, Hartford Hospital
10:25am - 11:15am | NET Year in Review
Moderator: Arvind N. Dasari, MD, MS, Professor, Department of Gastrointestinal (GI) Medical Oncology, The University of Texas MD Anderson Cancer Center
Topic: NET Year in Review
Speaker: Simron Singh, MD, MPH, Professor, University of Toronto; Provincial Head, Person Centered Care, Cancer Care Ontario; Medical Oncologist, Sunnybrook Odette Cancer Center/Susan Leslie Clinic for Neuroendocrine Cancers
11:15am - 11:30am | Break
11:30am - 12:30pm | NET MED 1: Disparities in NEN Care: Health Equity Across the Americas
Moderator: Julie Hallet, MD, MSc, FRCSC, Associate Professor, Department of Surgery, University of Toronto
Case Presenter: J. Bart Rose, MD, MAS, Associate Professor; Director, UAB Pancreatobiliary Disease Center; Chief, Section of Hepatopancreatobiliary Disease, The University of Alabama at Birmingham
Panelists:
Mysti Motz, MBA, BSN, RN, Quality & Regulation Manager, Norton Clark Hospital
Gabriela Alejandra Buerba, MD, MSc, National Institute of Medical Sciences and Nutrition Salvador Zubirán
Cecilia Carreras Velázquez, MD, Medical Director, Theranostics, Nuclear Medicine, PET/CT, Hospital Angeles Health System
John Metzcar, PhD, AMEND USA President and Postdoctoral Researcher, University of Minnesota College of Science and Engineering
12:30pm - 1:30pm | NETworking Lunch
12:30pm - 1:30pm | Satellite Symposia: An Exelixis Product for the Clinical Management of Neuroendocrine Tumors, supported by Exelixis
Walid Shaib, MD, Medical Oncologist, Northwest Georgia Oncology Centers Wellstar
1:35pm - 2:35pm | Society of Interventional Oncology Joint Session: Shifting Paradigms in IR: Navigating Clinical Trials, Predictive Biomarkers, and Next-Gen Liver Perfusion
Moderator: Sarah B. White, MD, MS, FSIR, FCIRSE, Associate Dean, Medical College of Wisconsin
Topic: Updates on IR Clinical Trials
Speaker: Renuka Iyer, MD, Professor of Oncology, Co- Leader Liver and Pancreas Tumor Program, Roswell Park Cancer Institute
Topic: Biomarkers Predictive of Response to Embolization and Future Directions
Speaker: Zachary T. Berman, MD, Assistant Professor of Radiology, University of California San Diego
Topic: Isolated Liver Perfusion
Speaker: Altan Ahmed, MD, Assistant Member, Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center
Topic: Joint NANETS/SSO/AHPBA/SIO Consensus Statement – Guidelines on Surgical and Liver-Directed Management of NETLM
Speaker: Daniel Anaya, MD, MSHCT, FACS, Professor and Chair, Department of GI Surgical Oncology/Gastroenterology, Moffitt Cancer Center
2:35pm - 3:05pm | PM Break
3:05pm - 4:05pm | NET MED 2: Biomarkers: Beyond Chromogranin A
Moderator: Daniel M. Halperin, MD, Vice Chair for Clinical Affairs, Associate Professor, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
Topic: Blood-Based Early Cancer Detection
Speaker: Neil Renwick, MD, PhD, Associate Professor, Queen's University, Ontario CA
Topic: Radiographic Biomarkers: Predictive and Prognostic Utility
Speaker: Thomas Hope, MD, Professor, Radiology, University of California, San Francisco
Topic: Cells, Proteins, and Tissue - Overview on current landscape and emerging utility
Speaker: Namrata Vijayvergia, MD, Section Chief, Gastrointestinal Medical Oncology; Associate Professor, Department of Hematology/Oncology; Medical Director, Medical Oncology, Fox Chase Cancer Center
4:10pm - 5:10pm | NET MED 3: Emerging Challenges in NENs: Immunotherapy, Toxicities, and Long-Term Management
Topic: Setting the Stage: Navigating Emerging Challenges and Evolving Patient Needs in NEN Care
Moderator & Speaker: Taymeyah Al-Toubah, MPH, Medical Student - MS1 (Italy)
Topic: Anticipating NEN Specific Toxicities with Emerging Immunotherapy (BiTE/CAR-T/TiLs)
Speaker: Christopher Doering, PhD, Professor, Department of Pediatrics, Emory University School of Medicine
Topic: Current vs. Ideal management of IO Toxicities: Rheumatologist Perspective
Speaker: Alexa Meara, MD, Associate Professor of Internal Medicine, Rheumatologist, Division of Oncology, The Ohio State University Wexner Medical Center
Topic: Topic: Are SSAs for life? (Dose escalation, combination, treatment beyond progression)
Speaker: Garima Gupta, MD, Assistant Professor of Medicine, O'Neal Cancer Center, The University of Alabama Birmingham
5:15pm - 6:15pm | Poster Tours
5:30pm - 6:30pm | Poster Reception
Friday October 24
SYMPOSIUM DAY 2
7:00am - 8:00am | Exhibit Hall Open
7:00am - 8:00am | Poster Hall Breakfast
7:00am - 8:00 am | Voices of Experience: Leadership Pathways in NET Care (Meet the Experts and other Early Career Members, RSVP by invite only)
7:00am - 8:00am | Satellite Symposia
8:00am - 9:00am | Society of Surgical Oncology and CUTNETs Joint Session: Bridging the Gap: Integrating Systemic and Surgical Therapy in Pancreatic NETs
Moderator: Janice Pasieka, MD, FRCSC, FACS, Clinical Professor of Surgery and Oncology, University of Calgary
Moderator: Julie Hallet, MD, MSc, FRCSC, Associate Professor, Department of Surgery, University of Toronto
Topic: Can response be generated in Pancreatic NETs?
Speaker: Alexandria T. Phan, MD, FACP, Professor, Medical College of Wisconsin
Topic: High-Risk Pancreatic NETs: Who, Why, and How?
Speaker: Stefano Partelli, MD, Assistant Professor of Surgery, Vita-salute San Raffaele University Milan, Italy
Topic: NETs Liver Metastases: expanding debulking with combination therapy
Speaker: Jess E. Maxwell, MD, MBA, Assistant Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center
Topic: From Advanced Disease to Perioperative Trials: how to bridge the gap?
Speaker: Syed A. Ahmad, MD, Professor of Clinical; Chief, Section of Surgical Oncology; Vice Chair for Faculty Development,, University of Cincinnati
9:05am - 10:20am | Featured Abstracts 1: Molecular Characterization and Interventional Strategies in NETs
Moderator: Erik S. Mittra, MD, PhD, Nuclear Medicine Physician; Professor of Diagnostic Radiology, School of Medicine, Oregon Health & Science University
Topic: Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET)
Speaker: Michael C. Soulen, MD, Professor of Radiology, Hospital of the University of Pennsylvania; Attending Staff, Interventional Radiology Section, University of Pennsylvania School of Medicine
Topic: Spatial and Transcriptional Profiling Reveals Immune Remodeling and Microenvironmental Heterogeneity in Benign and Malignant Pancreatic Neuroendocrine Tumors
Speaker: Gareth Pollin, PhD, Postdoctoral Researcher 3, Medical College of Wisconsin
Topic: Safety and Clinical Implications of Concurrent Biopsy of Neuroendocrine Liver Metastases at the time of Liver-Directed Therapy
Speaker: Rosa Thuemmler, MBChB, Honorary Clinical Fellow, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen UK
Topic: Spatial Transcriptomics Reveals Local Subtype-Specific Identity and Signaling within Multifocal Small Intestinal Neuroendocrine Tumors
Speaker: Akitada Yogo, PhD, Postdoctoral Scholar, Department of Surgery, Division of Surgical Oncology, University of California, San Francisco
Topic: Validation of Adversity-Linked Genes in Pancreatic Neuroendocrine Tumors
Speaker: Andrea Gillis, MD, Assistant Professor, Division of Breast and Endocrine Surgery, The University of Alabama Birmingham
10:20am - 10:40am | AM Break
10:40am - 11:40am | NET MED 4: Navigating Pheo/Para: Genetics, Management, and Emerging Therapeutics
Moderator: Justin P. Annes, MD, PhD, Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism, Stanford University
Topic: Genetics/Surveillance, Multidisciplinary Management of Pheo/Para
Speaker: Samantha Greenberg, PhD, MS, MPH, CGC, Director, Genetic Counseling Program; Assistant Professor, UT Southwestern AND Aisha Furqan, Genetic Counselor, Stanford Cancer Center
Speaker: Aisha Furqan, MS, CGC, Genetic Counselor, Stanford Cancer Center
Topic: Medical Management of Metastatic Disease
Speaker: Vineeth K. Sukrithan, MD, Assistant Professor in the College of Medicine, The Ohio State University
Topic: Models and Therapeutic Discovery
Speaker: Patricia L. M. Dahia, MD, PhD, Tenured Professor, School of Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA)
11:45 am – 12:20 pm | Lightning Pitch Competition
More details to come!
12:25pm - 1:30pm EDT | Annual Meeting and Luncheon
Facilitated by: Jennifer Chan, MD, MPH, Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School, NANETS President
1:30pm - 2:30pm | NETworking Break
1:45pm – 2:30pm | Patient Leaders Connect Meeting
2:30pm - 3:30pm | ENETS Joint Session
Moderator: Jennifer Chan, MD, MPH, Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School, NANETS President
Part I | Building successful research and clinical trials networks – What are we doing and what can we do to enhance collaboration?
Topic: GETNE why it works? What are the key factors?
Speaker: Rocio Garcia-Carbonero, MD, PhD Head of the GI and NE Tumor Unit, Hospital Universitario 12 de Octubre; Associate Professor of Oncology, Universidad Complutense in Madrid
Topic: NCTN NET network – what challenges are we facing?
Speaker: Heloisa Soares, MD, PhD, Medical Oncology, Huntsman Cancer Institute, University of Utah Health
Part II | Access to New Treatments - How can we bring innovative treatments to patients more quickly and effectively?
Topic: NANETS input
Speaker: Daniel M. Halperin, MD, Vice Chair for Clinical Affairs, Associate Professor, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University
Topic: ENETS input
Speaker: Thomas Walter, MD, PhD, Head of the Medical Oncology Department, Édouard-Herriot Hospital, Lyon, France; Professor of Medicine, University of Lyon; Head of the Neuroendocrine Neoplasm Program, European (EURACAN) Center of Excellence
3:35pm - 4:50pm | Featured Abstracts 2: Advancing Targeted Therapies and Molecular Imaging in GEP-NETs
Moderator: Hagen Kennecke, MD, MHA, FRCPC, Section Chief, Chief Health Officer, OHSU Knight-Legacy Health Cancer Collaborative
Topic: Efficacy of 177Lu-edotreotide vs Everolimus in patients with Grade 1 or Grade 2 GEP-NETs: Phase 3 COMPETE trial (post hoc subgroup analyses)
Speaker: Jaume Capdevila Castillon, MD, PhD, Senior Researcher, Department of Medical Oncology, Vall d'Hebron University Hospital & Vall d'Hebron Institute of Oncology
Topic: Phase 2 Study of Targeted Alpha Therapy 212Pb-DOTAMTATE in Patients with Advanced Gastroenteropancreatic (GEP)-NETs Previously Treated with PRRT
Speaker: Jonathan Strosberg, MD, Professor, Moffitt Cancer Center
Topic: Long-term Follow-up of PRRT-Naïve Patients with GEP-NETs Treated with Targeted Alpha Therapy 212Pb-DOTAMTATE in the Phase 2 ALPHAMEDIX 02 Trial
Speaker: Mary Maluccio, MD, MPH, FACS, Professor of Surgery, LSU School of Medicine
Topic: 61Cu-NODAGA-LM3 versus 68Ga-DOTATOC in the same patients with neuroendocrine tumors: Preliminary results of the Phase I/II COPPER-PET-in-NET Trial
Speaker: Guillaume Nicolas, MD, Deputy Division Head, University Hospital Basel, Switzerland
Topic: A SST14-based T-cell Engager for the treatment of Neuroendocrine Tumors
Speaker: Eleonora Pelle, MD, Post-Doctoral Researcher, Moffitt Cancer Center
4:50pm - 5:30pm | Cutting Edge Research
Moderator: Netta Mäkinen, PhD, Postdoctoral Fellow, Instructor, Dana-Farber Cancer Institute; Docent, University of Helsinki
Topic: Enhancer-Mediated regulation of Neuroendocrine Tumors and its Implications
Speaker: Yotam Drier, PhD, Genomics, Epigenomics and Topology of Cancer, Assistant Professor, Faculty of Medicine, Hebrew University of Jerusalem
6:00pm - 7:30pm | Dinner Satellite Symposia: Targeting NETs with Precision Imaging: Powering Clinical Decisions with Copper Cu 64 DOTATATE, supported by Curium
Speaker: Andreas Kjaer, MD, PhD, DMSc, Chief Physician, Copenhagen University; Professor, Department of Biomedical Sciences, Molecular Imaging, University of Copenhagen
Speaker: Simron Singh, MD, MPH, Professor, University of Toronto; Provincial Head, Person Centered Care, Cancer Care Ontario; Medical Oncologist, Sunnybrook Odette Cancer Center/Susan Leslie Clinic for Neuroendocrine Cancers
Dinner program by RSVP/ Invite only
Saturday October 25
SYMPOSIUM DAY 3
7:00am - 8:00am | Exhibit Hall Open
7:00am - 8:00am | Sponsor Connect Breakfast
7:30am - 8:00am | Dose Optimisation of SSAs: The Evolving Story in GEP-NET Management; Supported by Camurus
Moderator: Jennifer Chan, MD, MPH, Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School, NANETS President
Speaker: Simron Singh, MD, MPH, Professor, University of Toronto; Provincial Head, Person Centered Care, Cancer Care Ontario; Medical Oncologist, Sunnybrook Odette Cancer Center/Susan Leslie Clinic for Neuroendocrine Cancers
8:00am - 9:00am | NET MED 5: Ki-67 in NENs: From Guidelines to Clinical Realities
Moderator: Robert Ramirez, DO, FACP, Associate Professor of Medicine. Division of Hematology and Oncology, Vanderbilt University Medical Center
Topic: Guidelines vs. Reality - Are the current ki67 cutoffs appropriate for treatment decisions
Speaker: Chandrikha Chandrasekharan, MBBS, Associate Professor, GI Medical Oncology, The University of Texas MD Anderson Cancer Center
Topic: The difference that grade makes on Surgical Management and decisions
Speaker: Tanaz Vaghaiwalla, MD, MS, FACS, Endocrine Surgeon, Assistant Professor of Surgery, University of Miami
Topic: When Zebras Change Their Stripes - grade transformation in NENs
Speaker: Jason S. Starr, DO, Assistant Professor of Medicine, Division of Hematology/Oncology, Mayo Clinic
9:05am - 10:05am | Keynote Presentation | From Setbacks to SPORE: Advancing NET Research Through Teamwork and Tenacity
Moderator: Jennifer Chan, MD, MPH, Clinical Director, Gastrointestinal Cancer Center; Director, Program in Carcinoid and Neuroendocrine Tumors, Dana-Farber Cancer Institute; Associate Professor of Medicine, Harvard Medical School, NANETS President
Speaker: Dawn Quelle, PhD, Professor of Neuroscience and Pharmacology, The University of Iowa, Carver College of Medicine
10:05am - 10:20am | Break
10:20am - 11:20am | NET MED 6: Thor vs. AI: Integrating Artificial Intelligence into Clinical Decision-Making
Moderator: Mintallah Haider, MD, Associate Member, Department of Gastrointestinal Oncology, Moffitt Cancer Center; Associate Professor, Oncologic Sciences, University of South Florida
Topic: AI from the Patient Perspective
Speaker: Burt Rosen, Director of Marketing Innovations for Oregon State University, Patient
Topic: Thor vs. AI
Speaker: Thor R. Halfdanarson, MD, Professor of Oncology; Associate Professor of Medicine, Mayo Clinic
Panelist: Eric Nakakura, MD, PhD, Professor, The University of California San Francisco
11:25am - 12:30pm | Featured Abstracts 3: Evolving Care Models and Patient-Centered Perspectives in NETs
Moderator: Sarbajit Mukherjee, MD, MS, Chief of GI Medical Oncology, Miami Cancer Institute, Baptist Health South Florida
Topic: Care of Neuroendocrine Tumors: the Collaborative of Surgical Teams for NeuroEndocrine Tumors (CUTNETs)
Speaker: Julie Hallet, MD, MSc, FRCSC, Associate Professor, Department of Surgery, University of Toronto
Topic: An ongoing Phase 1 Trial of Obrixtamig in patients with Extrapulmonary Neuroendocrine Carcinomas with high or low DLL3 Expression
Speaker: Jaume Capdevila Castillon, MD, PhD, Senior Researcher, Department of Medical Oncology, Vall d'Hebron University Hospital & Vall d'Hebron Institute of Oncology
Topic: Distinct Sociodemographic, Symptom, and HRQoL Profiles in Early-Onset Neuroendocrine Tumors: Insights from the NET-PRO Study
Speaker: Udhayvir Singh Grewal, MD, Clinical Assistant Professor, Department of Hematology and Oncology, Winship Cancer Institute at Emory University
Topic: The Natural History of Small Bowel Neuroendocrine Tumor (SBNET) Metastases.
Speaker: Jeremy Chang, MS, MD, General Surgery Resident, University of Iowa Hospitals and Clinics
Topic: Quality of Life and Care Experiences in a U.S. Multi-Institutional Neuroendocrine Tumor Cohort
Speaker: Michael O'Rorke, PhD, Assistant Professor, University of Iowa
12:30pm - 1:30pm | Sponsor Connect Lunch
12:30pm - 1:30pm | Satellite Symposia: Understanding Advances in the Treatment of GEP-NETS, supported by Novartis
Speaker: Sandy Kotiah, MD, Director, The Neuroendocrine Tumor Center, Mercy Medical Center
1:35pm - 2:25pm | NET MED 7: Unpacking GLP-1: Expression, Clinical Integration, and Genetic Considerations
Moderator: Amanda Sturgeon, APRN, NP in Endocrinology, Moffitt Cancer Center
Topic: Clinical integration of GLP-1 into patient care - risks and clinical integration (MEN1, diabetes, syndromic patients, etc.)
Speaker: Joseph Dillon, MB, BCh, BAO, Professor of Internal Medicine-Endocrinology and Metabolism, Carver College of Medicine, The University of Iowa
Topic: GLP-1R expression levels in NET TMAs and NET models for testing GLP-1
Speaker: Po H. Ear, PhD, Research Assistant, Professor of Surgery-Surgical Oncology and Endocrine Surgery, University of Iowa
2:30pm - 3:30pm | Tumor Board: Management of Hormonal Crises in NENs
Case Presentation Topic: Complicated Insulinoma Case
Case Presenter: Udhayvir Singh Grewal, MD, Clinical Assistant Professor, Department of Hematology and Oncology, Winship Cancer Institute at Emory University
Case Presentation Topic: Complicated VIPoma
Case Presenter: Daneng Li, MD, Associate Professor, Department of Medical Oncology & Therapeutics Research, City of Hope
Panelists:
Jonathan Strosberg, MD, Professor, Moffitt Cancer Center
Callisia N. Clarke, MD, MS, FACS, FSSO, Associate Professor and Chief, Medical College of Wisconsin
Katelyn Sommerer, PharmD, MS, BCOP, Oncology Clinical Pharmacy Specialist, PGY1 Residency Program Director, Moffitt Cancer Center
Lisa Bodei, MD, PhD, Director of Targeted Radionuclide Therapy, Memorial Sloan Kettering Cancer Center
Gabriel Fine, MD, Associate Clinical Professor, Department of Diagnostic Radiology, City of Hope, Duarte, CA
Mark Jara, MD, Assistant Professor of Clinical Medicine, Miller School of Medicine, University of Miami
3:30pm - 4:00pm | Awards & Closing Remarks
Program is subject to change.